SAB Biotherapeutics (SABS) Net Margin (2021 - 2024)
SAB Biotherapeutics' Net Margin came in at -9934.52% for Q4 2024, down 2440.77 percentage points from -7493.75% a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Net Margin (2021 - 2024) Analysis & Trends
For FY2024, SAB Biotherapeutics' Net Margin was -2579.03%, down 694.53 percentage points from FY2023.
- Net Margin has declined in each of the last four years, with a four-year change of -2615.45 percentage points (FY2020 to FY2024).
- Going back by year, Net Margin was -1884.50% in FY2023 (-1806.10 pp), -78.40% in FY2022 (-50.24 pp), -28.16% in FY2021 (-64.58 pp) and 36.42% in FY2020.
- The Q4 2024 figure represents the lowest quarterly Net Margin in data going back to Q1 2021.
- Year-over-year, Net Margin increased in two of the last seven quarters, with an average year-over-year change of -1861.21 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q2 2024 (a gain of 5258.43 percentage points), and the weakest in Q2 2023 (a drop of 7970.92 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -9,934.52% |
| Jun 30, 2024 | -2,787.69% |
| Mar 31, 2024 | -532.06% |
| Dec 31, 2023 | -7,493.75% |
| Sep 30, 2023 | -402.59% |
| Jun 30, 2023 | -8,046.13% |
| Mar 31, 2023 | -1,265.50% |
| Dec 31, 2022 | -364.42% |
| Sep 30, 2022 | -197.12% |
| Jun 30, 2022 | -75.21% |
| Mar 31, 2022 | 8.35% |
| Dec 31, 2021 | -104.46% |
| Sep 30, 2021 | -27.66% |
| Jun 30, 2021 | -16.15% |
| Mar 31, 2021 | 8.33% |
API Access
SAB Biotherapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();